West Pharmaceutical Services (WST) Asset Utilization Ratio (2010 - 2026)

West Pharmaceutical Services has disclosed Asset Utilization Ratio across 17 years of filings, most recently posting 0.77 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.77, down 3.61% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.77 (down 3.61% YoY), and the FY2025 annual result was 0.78, changed 0.34% from the prior year.
• Asset Utilization Ratio came in at 0.77 for Q1 2026 at West Pharmaceutical Services, up from 0.73 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.88 in Q2 2022 to a low of 0.73 in Q4 2025.
• The 5-year median for Asset Utilization Ratio is 0.79 (2023), against an average of 0.8.
• Across the five-year window, Asset Utilization Ratio retreated 11.89% in 2023 and rose 4.65% in 2024, its largest moves.
• West Pharmaceutical Services' Asset Utilization Ratio stood at 0.83 in 2022, then retreated by 6.59% to 0.78 in 2023, then rose by 1.64% to 0.79 in 2024, then decreased by 7.16% to 0.73 in 2025, then gained by 4.73% to 0.77 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.77 (Q1 2026), 0.73 (Q4 2025), and 0.75 (Q3 2025), per Business Quant data.